Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

Leadership on prescription drugs needed

Edward Xie
CMAJ July 10, 2012 184 (10) 1175; DOI: https://doi.org/10.1503/cmaj.112-2050
Edward Xie
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

The article by Michael Law and coauthors raises issues germane to both clinical practice and public policy.1 After hospitals, drugs comprise Canada’s second greatest national health expenditure.2 That low-income and chronically ill Canadians struggle to maintain medication adherence is surprising.

The high cost of medications for people with chronic disease may also have effects beyond nonadherence. Patients have told me about sacrifices they have made, such as limiting dental care, child care or even food to afford their prescriptions. The relative benefits of each prescription should be weighed against these possible repercussions. Perhaps patients should be screened for cost-related nonadherence at the time of prescription.

Encouragingly, awareness about the cost of drugs is increasing among clinicians. Some hospitals I have worked at cite antibiotic costs on microbiology reports. Printed resources such as RxFiles3 and the Medication Use Management Services4 books are available for office practice. Additionally, drug price guides can be added to electronic medical record systems.

As the authors allude to, public policy is of critical importance and can and should have a role in reigning in nonadherence and expenditure on prescription drugs. A vast gap exists in the Canada Health Act that leaves drug coverage fragmented among the provinces and territories.5 Unifying this “patchwork” could be a cheaper and healthier option. It is time for Canada to follow the example of many other developed nations6 and seriously explore a national prescription drug strategy.

References

  1. ↵
    1. Law MR,
    2. Cheng L,
    3. Dhalla IA,
    4. et al
    . The effect of cost on adherence to prescription medications in Canada. CMAJ 2012;184:297–302.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Canadian Institute for Health Information. Drug expenditure in Canada, 1985 to 2010. Ottawa (ON): The Institute; 2010.
  3. ↵
    RxFiles. Saskatoon (SK): Saskatoon City Hospital. Available: www.rxfiles.ca (accessed 2012 Mar. 12).
  4. ↵
    Medication use management services. Toronto (ON). Available: http://mumshealth.com (accessed 2012 Mar. 12).
  5. ↵
    1. Demers V,
    2. Melo M,
    3. Jackevicius C,
    4. et al
    . Comparison of provincial prescription drug plans and the impact on patients’ annual drug expenditures. CMAJ 2008;178:405–9.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Thomson S,
    2. Mossialos E
    . Primary care and prescription drugs: coverage, cost-sharing, and financial protection in six European countries. Issue Brief (Commonw Fund) 2010;82:1–14.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 184 (10)
CMAJ
Vol. 184, Issue 10
10 Jul 2012
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Leadership on prescription drugs needed
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Leadership on prescription drugs needed
Edward Xie
CMAJ Jul 2012, 184 (10) 1175; DOI: 10.1503/cmaj.112-2050

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Leadership on prescription drugs needed
Edward Xie
CMAJ Jul 2012, 184 (10) 1175; DOI: 10.1503/cmaj.112-2050
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The denial of racism is racism itself
  • An expanded role for blood donor emerging pathogens surveillance
  • Beyond wastewater surveillance: refining environmental pathogen detection in the built environment
Show more Letters

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire